Alimentary Pharmacology & Therapeutics

Review article: acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms
pp. 1003-1017(15)
Authors: SIFRIM, D.; MITTAL, R.; FASS, R.; SMOUT, A.; CASTELL, D.; TACK, J.; GREGERSEN, H.

Systematic review: renal and other clinically relevant outcomes in hepatorenal syndrome trials
pp. 1017-1028(12)
Authors: TANDON, P.; BAIN, V. G.; TSUYUKI, R. T.; KLARENBACH, S.

Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1386-patient study from Taiwan
pp. 1029-1037(9)
Authors: HUANG, J.-F.; YU, M.-L.; LEE, C.-M.; DAI, C.-Y.; HOU, N.-J.; HSIEH, M.-Y.; WANG, J.-H.; LU, S.-N.; SHEEN, I.-S.; LIN, S.-M.; CHUANG, W.-L.; LIAW, Y.-F.

A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy
pp. 1039-1046(8)
Authors: ANNICCHIARICO, B. E.; SICILIANO, M.; AVOLIO, A. W.; GRILLO, R. L.; BOMBARDIERI, G.

Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features
pp. 1047-1054(8)
Authors: MATHURIN, P.; BEUZIN, F.; LOUVET, A.; CARRIÉ-GANNE, N.; BALIAN, A.; TRINCHET, J. C.; DALSOGLIO, D.; PREVOT, S.; NAVEAU, S.

Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006
pp. 1055-1060(6)
Authors: JAKOBOVITS, S. L.; JEWELL, D. P.; TRAVIS, S. P. L.

Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin
pp. 1061-1067(7)
Authors: CASELLAS, F.; BORRUEL, N.; TORREJÓN, A.; VARELA, E.; ANTOLIN, M.; GUARNER, F.; MALAGELADA, J.-R.

Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease
pp. 1069-1077(9)
Authors: WINTER, J. W.; GAFFNEY, D.; SHAPIRO, D; SPOONER, R. J.; MARINAKI, A. M.; SANDERSON, J. D.; MILLS, P. R.

Does body mass index differ between patients with Barrett's oesophagus and patients with chronic gastro-oesophageal reflux disease?
pp. 1079-1086(8)
Authors: GERSON, L. B.; ULLAH, N.; FASS, R.; GREEN, C.; SHETLER, K.; SINGH, G.

Symptom overlap in patients with upper gastrointestinal complaints in the Canadian confirmatory acid suppression test (CAST) study: further psychometric validation of the reflux disease questionnaire
pp. 1087-1097(11)
Authors: VAN ZANTEN, S. V.; ARMSTRONG, D.; BARKUN, A.; JUNGHARD, O.; WHITE, R. J.; WIKLUND, I. K.

Positive association between gastro-oesophageal reflux disease and irritable bowel syndrome in a Chinese population
pp. 1099-1104(6)
Authors: CHEUNG, T. K.; LAM, K. F.; HU, W. H. C.; LAM, C. L. K.; WONG, W. M.; HUI, W. M.; LAI, K. C.; LAM, S. K.; WONG, B. C. Y

Rabeprazole-based eradication therapy for Helicobacter pylori: a large-scale study in Japan
pp. 1105-1113(9)
Authors: KUWAYAMA, H.; ASAKA, M.; SUGIYAMA, T.; FUKUDA, Y.; AOYAMA, N.; HIRAI, Y.; FUJIOKA, T.

Acute exacerbation of pain in irritable bowel syndrome: efficacy of phloroglucinol/trimethylphloroglucinol - a randomized, double-blind, placebo-controlled study
pp. 1115-1123(9)
Authors: CHASSANY, O.; BONAZ, B.; BRULEY DES VARANNES, S.; BUENO, L.; CARGILL, G.; COFFIN, B.; DUCROTTÉ, P.; GRANGÉ, V.

Elastomer implants in faecal incontinence: a blind, randomized placebo-controlled study
pp. 1125-1132(8)
Authors: SIPROUDHIS, L.; MORCET, J.; LAINÉ, F.

Bone disease in primary biliary cirrhosis and renal tubular acidosis
pp. 1133-1134(2)
Authors: Farias, A. Q.; Gonçalves, L. L.; Cançado, E. L. R.; Carrilho, F. J.

Bone disease in primary biliary cirrhosis and renal tubular acidosis: authors' reply
pp. 1134-1134(1)
Authors: Allocca, M.; Crosignani, A.; Benetti, A.; Battezzati, P. M.